CONMED Corporation (CNMD)
USD 69.32
(-2.68%)
USD 69.32
(-2.68%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 182.18 Million USD | 534.22% |
| 2022 | 7.79 Million USD | -138.64% |
| 2021 | 158.38 Million USD | 137.85% |
| 2020 | 113.58 Million USD | -38.24% |
| 2019 | 124.91 Million USD | 3.68% |
| 2018 | 133.1 Million USD | 51.92% |
| 2017 | 105.48 Million USD | -47.87% |
| 2016 | 90.04 Million USD | -5.27% |
| 2015 | 95.05 Million USD | -3.52% |
| 2014 | 98.52 Million USD | -5.61% |
| 2013 | 104.11 Million USD | -6.66% |
| 2012 | 111.82 Million USD | 0.51% |
| 2011 | 47.05 Million USD | 12.5% |
| 2010 | 94.57 Million USD | 42.2% |
| 2009 | 66.52 Million USD | -35.36% |
| 2008 | 111.97 Million USD | -3.54% |
| 2007 | 112.52 Million USD | 43.32% |
| 2006 | 25.24 Million USD | -23.44% |
| 2005 | 94.53 Million USD | -8.58% |
| 2004 | 89.2 Million USD | -11.59% |
| 2003 | 112.7 Million USD | 23.64% |
| 2002 | 101.71 Million USD | 2.64% |
| 2001 | 99.1 Million USD | 5.49% |
| 2000 | 93.95 Million USD | -6.52% |
| 1999 | 100.5 Million USD | 18.51% |
| 1998 | 84.8 Million USD | 22.54% |
| 1997 | 32.8 Million USD | 116.25% |
| 1996 | 32 Million USD | 34.45% |
| 1995 | 23.8 Million USD | 85.94% |
| 1994 | 12.8 Million USD | 700.0% |
| 1993 | 1.4 Million USD | -79.22% |
| 1992 | 8 Million USD | -2.53% |
| 1991 | 8.2 Million USD | 36.67% |
| 1990 | 6 Million USD | 361.54% |
| 1989 | 1.3 Million USD | -23.53% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 54.93 Million USD | -9.91% |
| 2024 Q3 | 65.7 Million USD | 77.64% |
| 2024 Q2 | 49.97 Million USD | -14.25% |
| 2023 Q3 | 30.3 Million USD | 10.51% |
| 2023 Q4 | 60.97 Million USD | 101.23% |
| 2023 FY | - USD | 534.22% |
| 2023 Q2 | 27.41 Million USD | 115.91% |
| 2023 Q1 | 12.69 Million USD | 1259.73% |
| 2022 Q3 | 24.24 Million USD | 127.7% |
| 2022 Q4 | -1.09 Million USD | -104.52% |
| 2022 Q1 | 22.44 Million USD | -39.69% |
| 2022 FY | - USD | -138.64% |
| 2022 Q2 | -87.55 Million USD | -490.1% |
| 2021 Q2 | 25.7 Million USD | 28.01% |
| 2021 Q1 | 20.08 Million USD | -18.41% |
| 2021 Q3 | 25.58 Million USD | -0.48% |
| 2021 Q4 | 37.21 Million USD | 45.47% |
| 2021 FY | - USD | 137.85% |
| 2020 Q4 | 24.61 Million USD | -15.98% |
| 2020 Q3 | 29.29 Million USD | 1035.58% |
| 2020 Q2 | -3.13 Million USD | -123.93% |
| 2020 Q1 | 13.08 Million USD | -52.53% |
| 2020 FY | - USD | -38.24% |
| 2019 Q1 | 7.41 Million USD | -71.3% |
| 2019 FY | - USD | 3.68% |
| 2019 Q2 | 18.33 Million USD | 147.4% |
| 2019 Q3 | 20.61 Million USD | 12.44% |
| 2019 Q4 | 27.55 Million USD | 33.66% |
| 2018 FY | - USD | 51.92% |
| 2018 Q2 | 31.92 Million USD | -1.84% |
| 2018 Q1 | 32.52 Million USD | 40.36% |
| 2018 Q4 | 25.82 Million USD | -5.18% |
| 2018 Q3 | 27.23 Million USD | -14.7% |
| 2017 Q3 | 28.33 Million USD | 4.7% |
| 2017 Q1 | 11.43 Million USD | -9.33% |
| 2017 FY | - USD | -47.87% |
| 2017 Q4 | 23.17 Million USD | -18.2% |
| 2017 Q2 | 27.05 Million USD | 136.74% |
| 2016 FY | - USD | -5.27% |
| 2016 Q4 | 12.6 Million USD | -54.6% |
| 2016 Q1 | 13.85 Million USD | -43.54% |
| 2016 Q3 | 27.76 Million USD | 27.85% |
| 2016 Q2 | 21.71 Million USD | 56.74% |
| 2015 FY | - USD | -3.52% |
| 2015 Q3 | 26.06 Million USD | 11.74% |
| 2015 Q4 | 24.53 Million USD | -5.86% |
| 2015 Q2 | 23.32 Million USD | 10.43% |
| 2015 Q1 | 21.12 Million USD | -26.66% |
| 2014 Q1 | 28.17 Million USD | -1.16% |
| 2014 FY | - USD | -5.61% |
| 2014 Q3 | 14.16 Million USD | -48.26% |
| 2014 Q2 | 27.37 Million USD | -2.84% |
| 2014 Q4 | 28.8 Million USD | 103.34% |
| 2013 Q1 | 27.59 Million USD | 62.19% |
| 2013 FY | - USD | -6.66% |
| 2013 Q4 | 28.5 Million USD | 38.86% |
| 2013 Q3 | 20.53 Million USD | -25.99% |
| 2013 Q2 | 27.73 Million USD | 0.51% |
| 2012 FY | - USD | 0.51% |
| 2012 Q3 | 25.82 Million USD | -8.8% |
| 2012 Q2 | 28.31 Million USD | -1.82% |
| 2012 Q1 | 28.83 Million USD | -0.56% |
| 2012 Q4 | 17.01 Million USD | -34.1% |
| 2011 Q4 | 28.99 Million USD | 8.62% |
| 2011 FY | - USD | 12.5% |
| 2011 Q2 | 27.4 Million USD | -0.72% |
| 2011 Q3 | 26.69 Million USD | -2.59% |
| 2011 Q1 | 27.6 Million USD | 19.04% |
| 2010 Q2 | 25.07 Million USD | 5.18% |
| 2010 Q3 | 25.71 Million USD | 2.54% |
| 2010 Q4 | 23.18 Million USD | -9.83% |
| 2010 FY | - USD | 42.2% |
| 2010 Q1 | 23.84 Million USD | 13.18% |
| 2009 Q2 | 5.03 Million USD | -63.15% |
| 2009 FY | - USD | -35.36% |
| 2009 Q4 | 21.06 Million USD | 67.52% |
| 2009 Q3 | 12.57 Million USD | 149.77% |
| 2009 Q1 | 13.66 Million USD | -37.34% |
| 2008 Q4 | 21.8 Million USD | -17.94% |
| 2008 Q3 | 26.57 Million USD | -12.46% |
| 2008 Q2 | 30.35 Million USD | 5.14% |
| 2008 Q1 | 28.86 Million USD | -12.74% |
| 2008 FY | - USD | -3.54% |
| 2007 Q3 | 25.02 Million USD | -10.51% |
| 2007 Q2 | 27.96 Million USD | 9.86% |
| 2007 FY | - USD | 43.32% |
| 2007 Q4 | 33.08 Million USD | 32.19% |
| 2007 Q1 | 25.45 Million USD | 57.87% |
| 2006 Q4 | 16.12 Million USD | -22.99% |
| 2006 FY | - USD | -23.44% |
| 2006 Q3 | 20.94 Million USD | -0.92% |
| 2006 Q2 | 21.13 Million USD | 11.07% |
| 2006 Q1 | 19.02 Million USD | 8.43% |
| 2005 FY | - USD | -8.58% |
| 2005 Q4 | 17.54 Million USD | -28.48% |
| 2005 Q3 | 24.53 Million USD | -18.13% |
| 2005 Q2 | 29.97 Million USD | 1.41% |
| 2005 Q1 | 29.55 Million USD | 106.53% |
| 2004 Q1 | 28.57 Million USD | -23.35% |
| 2004 Q4 | 14.31 Million USD | -64.71% |
| 2004 Q2 | 27.75 Million USD | -2.88% |
| 2004 Q3 | 40.55 Million USD | 46.12% |
| 2004 FY | - USD | -11.59% |
| 2003 Q2 | 16.46 Million USD | 5.06% |
| 2003 Q4 | 37 Million USD | 40.38% |
| 2003 Q1 | 33.84 Million USD | 10.21% |
| 2003 FY | - USD | 23.64% |
| 2003 Q3 | 25.4 Million USD | -4.06% |
| 2002 FY | - USD | 2.64% |
| 2002 Q1 | 26.21 Million USD | 0.46% |
| 2002 Q2 | 25.98 Million USD | -0.87% |
| 2002 Q3 | 25.61 Million USD | -1.43% |
| 2002 Q4 | 23.9 Million USD | -6.65% |
| 2001 Q1 | 25.27 Million USD | -5.12% |
| 2001 FY | - USD | 5.49% |
| 2001 Q4 | 26.09 Million USD | 11.46% |
| 2001 Q3 | 23.41 Million USD | -3.77% |
| 2001 Q2 | 24.32 Million USD | -3.75% |
| 2000 FY | - USD | -6.52% |
| 2000 Q1 | 26.76 Million USD | -6.41% |
| 2000 Q2 | 20.55 Million USD | -23.22% |
| 2000 Q3 | 19.99 Million USD | -2.71% |
| 2000 Q4 | 26.63 Million USD | 33.23% |
| 1999 Q1 | 23.8 Million USD | 0.0% |
| 1999 Q2 | 24.6 Million USD | 3.36% |
| 1999 Q4 | 28.6 Million USD | 22.22% |
| 1999 Q3 | 23.4 Million USD | -4.88% |
| 1999 FY | - USD | 18.51% |
| 1998 Q3 | 23.1 Million USD | 10.53% |
| 1998 FY | - USD | 22.54% |
| 1998 Q2 | 20.9 Million USD | 23.67% |
| 1998 Q4 | 23.8 Million USD | 3.03% |
| 1998 Q1 | 16.9 Million USD | -61.76% |
| 1997 Q1 | 7.6 Million USD | 17.07% |
| 1997 Q3 | 8.9 Million USD | 37.5% |
| 1997 Q2 | 6.8 Million USD | -33.33% |
| 1997 Q4 | 9.3 Million USD | 402.27% |
| 1997 FY | - USD | 116.25% |
| 1996 Q3 | 8.2 Million USD | 0.0% |
| 1996 Q1 | 7.2 Million USD | -2.7% |
| 1996 Q4 | 8.2 Million USD | 1.23% |
| 1996 FY | - USD | 34.45% |
| 1996 Q2 | 8.3 Million USD | 12.5% |
| 1995 Q1 | 4 Million USD | 8.11% |
| 1995 Q4 | 7.4 Million USD | 19.35% |
| 1995 Q3 | 6.2 Million USD | -1.59% |
| 1995 FY | - USD | 85.94% |
| 1995 Q2 | 6.3 Million USD | 57.5% |
| 1994 Q1 | 3 Million USD | 225.0% |
| 1994 FY | - USD | 700.0% |
| 1994 Q4 | 3.7 Million USD | 12.12% |
| 1994 Q3 | 3.3 Million USD | 10.0% |
| 1994 Q2 | 3 Million USD | 0.0% |
| 1993 Q3 | 2.4 Million USD | 177.78% |
| 1993 Q4 | -2.4 Million USD | -196.0% |
| 1993 FY | - USD | -79.22% |
| 1993 Q1 | 1.3 Million USD | -18.75% |
| 1993 Q2 | 900 Thousand USD | -30.77% |
| 1992 Q2 | 2.5 Million USD | 4.35% |
| 1992 Q1 | 2.4 Million USD | 0.0% |
| 1992 FY | - USD | -2.53% |
| 1992 Q3 | 1.9 Million USD | -20.83% |
| 1992 Q4 | 1.7 Million USD | -15.79% |
| 1991 FY | - USD | 31.67% |
| 1991 Q1 | 1.9 Million USD | 35.71% |
| 1991 Q4 | 2.3 Million USD | 15.0% |
| 1991 Q3 | 2.1 Million USD | 0.0% |
| 1991 Q2 | 2 Million USD | 5.26% |
| 1990 Q2 | 1.6 Million USD | 6.67% |
| 1990 FY | - USD | 400.0% |
| 1990 Q4 | 1.4 Million USD | -17.65% |
| 1990 Q3 | 1.7 Million USD | 6.25% |
| 1990 Q1 | 1.5 Million USD | 275.0% |
| 1989 Q2 | 4.4 Million USD | 12.82% |
| 1989 Q4 | 400 Thousand USD | 300.0% |
| 1989 FY | - USD | -20.0% |
| 1989 Q1 | 3.9 Million USD | 141.05% |
| 1989 Q3 | 100 Thousand USD | -97.73% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Abbott Laboratories | 10.46 Billion USD | 98.259% |
| Allurion Technologies Inc. | -69.03 Million USD | 363.919% |
| Artivion, Inc. | 38.14 Million USD | -377.652% |
| Avanos Medical, Inc. | 53.2 Million USD | -242.455% |
| Butterfly Network, Inc. | -124.84 Million USD | 245.931% |
| Butterfly Network, Inc. | -124.84 Million USD | 245.931% |
| Bio-Rad Laboratories, Inc. | -608.26 Million USD | 129.952% |
| Boston Scientific Corporation | 3.45 Billion USD | 94.724% |
| Perspective Therapeutics, Inc. | -14.83 Million USD | 1327.834% |
| Edwards Lifesciences Corporation | 1.76 Billion USD | 89.693% |
| Paragon 28, Inc. | -36.61 Million USD | 597.586% |
| Glaukos Corporation | -82.11 Million USD | 321.864% |
| Globus Medical, Inc. | 418.23 Million USD | 56.44% |
| Inspire Medical Systems, Inc. | -17.06 Million USD | 1167.913% |
| Integer Holdings Corporation | 282.05 Million USD | 35.409% |
| Medtronic plc | 9.05 Billion USD | 97.988% |
| Nevro Corp. | -78.31 Million USD | 332.647% |
| Owlet, Inc. | -27.48 Million USD | 762.76% |
| Penumbra, Inc. | 111.99 Million USD | -62.672% |
| Vicarious Surgical Inc. | -69.19 Million USD | 363.305% |
| Smith & Nephew plc | 979 Million USD | 81.391% |
| Sonendo, Inc. | -54.76 Million USD | 432.65% |
| STERIS plc | 1.41 Billion USD | 87.101% |
| Stryker Corporation | 5.16 Billion USD | 96.469% |
| Vapotherm, Inc. | -34.35 Million USD | 630.273% |
| Zimmer Biomet Holdings, Inc. | 2.44 Billion USD | 92.56% |